• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

每个新生儿:超越生存的进展、优先事项和潜力。

Every Newborn: progress, priorities, and potential beyond survival.

机构信息

Centre for Maternal Reproductive & Child Health, and Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK; Saving Newborn Lives/Save the Children USA, Washington, DC, USA; Research and Evidence Division, Department for International Development, London, UK.

Centre for Maternal Reproductive & Child Health, and Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.

出版信息

Lancet. 2014 Jul 12;384(9938):189-205. doi: 10.1016/S0140-6736(14)60496-7. Epub 2014 May 19.

DOI:10.1016/S0140-6736(14)60496-7
PMID:24853593
Abstract

In this Series paper, we review trends since the 2005 Lancet Series on Neonatal Survival to inform acceleration of progress for newborn health post-2015. On the basis of multicountry analyses and multi-stakeholder consultations, we propose national targets for 2035 of no more than 10 stillbirths per 1000 total births, and no more than 10 neonatal deaths per 1000 livebirths, compatible with the under-5 mortality targets of no more than 20 per 1000 livebirths. We also give targets for 2030. Reduction of neonatal mortality has been slower than that for maternal and child (1-59 months) mortality, slowest in the highest burden countries, especially in Africa, and reduction is even slower for stillbirth rates. Birth is the time of highest risk, when more than 40% of maternal deaths (total about 290,000) and stillbirths or neonatal deaths (5·5 million) occur every year. These deaths happen rapidly, needing a rapid response by health-care workers. The 2·9 million annual neonatal deaths worldwide are attributable to three main causes: infections (0·6 million), intrapartum conditions (0·7 million), and preterm birth complications (1·0 million). Boys have a higher biological risk of neonatal death, but girls often have a higher social risk. Small size at birth--due to preterm birth or small-for-gestational-age (SGA), or both--is the biggest risk factor for more than 80% of neonatal deaths and increases risk of post-neonatal mortality, growth failure, and adult-onset non-communicable diseases. South Asia has the highest SGA rates and sub-Saharan Africa has the highest preterm birth rates. Babies who are term SGA low birthweight (10·4 million in these regions) are at risk of stunting and adult-onset metabolic conditions. 15 million preterm births, especially of those younger than 32 weeks' gestation, are at the highest risk of neonatal death, with ongoing post-neonatal mortality risk, and important risk of long-term neurodevelopmental impairment, stunting, and non-communicable conditions. 4 million neonates annually have other life-threatening or disabling conditions including intrapartum-related brain injury, severe bacterial infections, or pathological jaundice. Half of the world's newborn babies do not get a birth certificate, and most neonatal deaths and almost all stillbirths have no death certificate. To count deaths is crucial to change them. Failure to improve birth outcomes by 2035 will result in an estimated 116 million deaths, 99 million survivors with disability or lost development potential, and millions of adults at increased risk of non-communicable diseases after low birthweight. In the post-2015 era, improvements in child survival, development, and human capital depend on ensuring a healthy start for every newborn baby--the citizens and workforce of the future.

摘要

在本系列论文中,我们回顾了自 2005 年《柳叶刀》新生儿生存系列报告以来的趋势,以期为 2015 年后新生儿健康的加速发展提供信息。基于多国分析和多方利益攸关方协商,我们提出了 2035 年的国家目标,即每 1000 例总分娩中死产不超过 10 例,每 1000 例活产中新生儿死亡不超过 10 例,这与每 1000 例活产中 5 岁以下儿童死亡率不超过 20 例的目标一致。我们还给出了 2030 年的目标。新生儿死亡率的下降速度慢于母婴(1-59 个月)死亡率,在负担最重的国家最慢,特别是在非洲,死产率的下降速度甚至更慢。分娩时的风险最高,每年有超过 40%的孕产妇死亡(总计约 29 万)和死产或新生儿死亡(550 万)发生。这些死亡发生得很快,需要医护人员迅速做出反应。全世界每年有 290 万新生儿死亡,主要归因于三个原因:感染(60 万)、分娩期间状况(70 万)和早产并发症(100 万)。男孩的新生儿死亡生物学风险较高,但女孩的社会风险往往较高。出生体重较小--由于早产或小于胎龄(SGA),或两者兼而有之--是超过 80%的新生儿死亡的最大风险因素,并增加了新生儿后死亡率、生长发育不良和成年后非传染性疾病的风险。南亚的 SGA 发生率最高,撒哈拉以南非洲的早产率最高。这些地区的足月 SGA 低出生体重儿(1040 万)有发育迟缓及成年后代谢疾病的风险。1500 万例早产,特别是妊娠 32 周以下的早产,面临着最高的新生儿死亡风险,以及持续的新生儿后死亡率风险和重要的长期神经发育损伤、发育迟缓及非传染性疾病风险。每年有 400 万新生儿患有其他危及生命或致残的疾病,包括分娩期间相关脑损伤、严重细菌感染或病理性黄疸。全世界一半的新生儿没有出生证明,几乎所有的死产和死产都没有死亡证明。要计算死亡人数,必须改变这种情况。如果到 2035 年仍不能改善出生结局,预计将有 1.16 亿人死亡,9900 万人有残疾或丧失发展潜力,数百万人因出生体重低而面临非传染性疾病风险增加。在后 2015 年时代,儿童生存、发展和人力资本的改善取决于确保每个新生儿都有一个健康的开端--这是未来的公民和劳动力。

相似文献

1
Every Newborn: progress, priorities, and potential beyond survival.每个新生儿:超越生存的进展、优先事项和潜力。
Lancet. 2014 Jul 12;384(9938):189-205. doi: 10.1016/S0140-6736(14)60496-7. Epub 2014 May 19.
2
Population-based rates, timing, and causes of maternal deaths, stillbirths, and neonatal deaths in south Asia and sub-Saharan Africa: a multi-country prospective cohort study.南亚和撒哈拉以南非洲地区基于人群的孕产妇死亡、死产和新生儿死亡的发生率、时间和原因:一项多国前瞻性队列研究。
Lancet Glob Health. 2018 Dec;6(12):e1297-e1308. doi: 10.1016/S2214-109X(18)30385-1. Epub 2018 Oct 22.
3
Small babies, big risks: global estimates of prevalence and mortality for vulnerable newborns to accelerate change and improve counting.小婴儿,大风险:脆弱新生儿的全球患病率和死亡率估计数,以加速变革和改善计数。
Lancet. 2023 May 20;401(10389):1707-1719. doi: 10.1016/S0140-6736(23)00522-6. Epub 2023 May 8.
4
Global, regional, and national stillbirths at 20 weeks' gestation or longer in 204 countries and territories, 1990-2021: findings from the Global Burden of Disease Study 2021.204 个国家和地区 1990 至 2021 年 20 孕周或以上的全球、区域和国家死产:2021 年全球疾病负担研究结果。
Lancet. 2024 Nov 16;404(10466):1955-1988. doi: 10.1016/S0140-6736(24)01925-1. Epub 2024 Nov 4.
5
Global, regional, and national estimates and trends in stillbirths from 2000 to 2019: a systematic assessment.全球、区域和国家 2000 年至 2019 年死产估计数和趋势:系统评估。
Lancet. 2021 Aug 28;398(10302):772-785. doi: 10.1016/S0140-6736(21)01112-0.
6
Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.1980 - 2015年全球、区域、国家及部分国家以下各级死产、新生儿、婴儿及5岁以下儿童死亡率:全球疾病负担研究2015的系统分析
Lancet. 2016 Oct 8;388(10053):1725-1774. doi: 10.1016/S0140-6736(16)31575-6.
7
Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019.全球、区域和国家在实现可持续发展目标 3.2 方面的进展:2019 年全球疾病负担研究中新生儿和儿童健康的全因和病因特异性死亡率结果。
Lancet. 2021 Sep 4;398(10303):870-905. doi: 10.1016/S0140-6736(21)01207-1. Epub 2021 Aug 17.
8
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.1990年和2010年20个年龄组中235种死因的全球和区域死亡率:全球疾病负担研究2010的系统分析
Lancet. 2012 Dec 15;380(9859):2095-128. doi: 10.1016/S0140-6736(12)61728-0.
9
Global report on preterm birth and stillbirth (1 of 7): definitions, description of the burden and opportunities to improve data.全球早产儿和死产报告(1/7):定义、负担描述和改善数据的机会。
BMC Pregnancy Childbirth. 2010 Feb 23;10 Suppl 1(Suppl 1):S1. doi: 10.1186/1471-2393-10-S1-S1.
10
National, regional, and global estimates of preterm birth in 2020, with trends from 2010: a systematic analysis.2020 年全球、区域和国家早产估计数及其 2010 年以来的变化趋势:系统分析。
Lancet. 2023 Oct 7;402(10409):1261-1271. doi: 10.1016/S0140-6736(23)00878-4.

引用本文的文献

1
Evaluation of whole blood CD64 for identifying infection in neonates receiving hospital care.评估全血CD64用于识别接受住院治疗的新生儿感染情况。
Front Immunol. 2025 Aug 18;16:1629223. doi: 10.3389/fimmu.2025.1629223. eCollection 2025.
2
Risk prediction of healthcare-associated neonatal sepsis in Amhara, Ethiopia: A prospective cohort study.埃塞俄比亚阿姆哈拉地区医疗相关新生儿败血症的风险预测:一项前瞻性队列研究。
Glob Pediatr. 2025 Sep;13:None. doi: 10.1016/j.gpeds.2025.100268.
3
Comparative analysis of predictors of child mortality in Ethiopia via frequentist and Bayesian approaches.
通过频率论和贝叶斯方法对埃塞俄比亚儿童死亡率预测因素的比较分析。
Sci Rep. 2025 Aug 27;15(1):31582. doi: 10.1038/s41598-025-02059-y.
4
Barriers and facilitators to facility-based feeding support for small and sick newborns in Ethiopia: a qualitative study of clinicians' perspectives.埃塞俄比亚为患病新生儿提供基于医疗机构的喂养支持的障碍与促进因素:对临床医生观点的定性研究
BMJ Open. 2025 Aug 25;15(8):e098616. doi: 10.1136/bmjopen-2024-098616.
5
Efficacy of zinc supplementation for young infants with clinical severe infection in Tanzania: study protocol for a randomised controlled trial.坦桑尼亚临床严重感染的低龄婴儿补充锌的疗效:一项随机对照试验的研究方案
BMJ Paediatr Open. 2025 Aug 14;9(1):e003804. doi: 10.1136/bmjpo-2025-003804.
6
Trends in adverse perinatal outcomes and associated hospitalisations, emergency department presentations, and healthcare costs from birth to early childhood in the Northern Territory, Australia: A two-decade population-based study.澳大利亚北领地围产期不良结局及其相关住院治疗、急诊科就诊情况以及从出生到幼儿期的医疗保健费用趋势:一项基于人群的二十年研究。
PLOS Glob Public Health. 2025 Aug 7;5(8):e0004985. doi: 10.1371/journal.pgph.0004985. eCollection 2025.
7
Incidence and predictors of mortality among low birth weight neonates in Africa: a systematic review and meta-analysis.非洲低出生体重新生儿的死亡率及其预测因素:一项系统评价和荟萃分析
Front Pediatr. 2025 Jul 15;13:1458871. doi: 10.3389/fped.2025.1458871. eCollection 2025.
8
The Effect of Intravenous Albumin Administration Before Exchange Transfusion in Infants With Hyperbilirubinemia: A Meta-Analysis.换血治疗前静脉输注白蛋白对高胆红素血症婴儿的影响:一项荟萃分析。
Health Sci Rep. 2025 Jul 27;8(8):e71079. doi: 10.1002/hsr2.71079. eCollection 2025 Aug.
9
Neonatal complications and referral practices at birth: insights from a population-based study in the Indian state of Bihar.新生儿出生时的并发症及转诊情况:来自印度比哈尔邦一项基于人群研究的见解
BMJ Open. 2025 Jul 20;15(7):e098408. doi: 10.1136/bmjopen-2024-098408.
10
Illicit substance exposure in pregnancy and infant mortality risk: a nationwide Taiwan study.孕期非法药物暴露与婴儿死亡风险:一项台湾地区的全国性研究。
Int J Neuropsychopharmacol. 2025 Aug 1;28(8). doi: 10.1093/ijnp/pyaf046.